Sound Pharmaceuticals, Inc
- Biotech or pharma, therapeutic R&D
Pioneering neurotology company with multiple Phase 2/3 programs in hearing loss, tinnitus, and ototoxicity. Recently completed Phase 3 in Meniere's disease achieved co-primary endpoints and is Fast Tracked. Expanding into multiple neuropsychiatric indications including bipolar mania, schizophrenia and autism.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}